PAD for Vascular Specialists

These activities were developed through a collaboration between Society for Vascular Medicine and Medscape Education. Supported by an independent educational grant from Janssen Pharmaceuticals, Inc.

IMPROVING ANTITHROMBOTIC THERAPY IN PATIENTS WITH PERIPHERAL ARTERY DISEASE: VASCULAR SPECIALIST APPROACHES

0.25 ABIM MOC / CE

Despite affecting more than 200 million people globally, patients with peripheral artery disease (PAD) are often untreated. Learn more from our vascular experts.

Authors: Herbert D. Aronow, MD, MPH, FACC, FSCAI, FSVM; Esther S.H. Kim, MD, MPH, RPVI, FSVM

CME / ABIM MOC Released: 7/28/2023
Valid for credit through: 7/28/2024

Learn More

MANAGING PERIPHERAL ARTERY DISEASE POST-REVASCULARIZATION: TRANSLATING NEW DATA INTO PRACTICE

0.25 CME / ABIM MOC

Improve outcomes in post-revascularization patients with peripheral artery disease (PAD). Integrate the latest data for using dual antithrombotic therapy.

Authors: Joshua Beckman, MD; Charles P. Vega, MD

Authors: Joshua Beckman, MD; Charles P. Vega, MD
CME / ABIM MOC Released: 12/12/2022
Valid for credit through: 12/12/2023

Learn More

APPROACHES TO THE ANKLE-BRACHIAL INDEX FOR DIAGNOSING PERIPHERAL ARTERY DISEASE: FROM TESTING TO INTERPRETATION

0.25 CME / ABIM MOC

Want to know when and how to use the ankle-brachial index (ABI) to identify patients with peripheral artery disease (PAD)?

Authors: Soo Hyun (Esther) Kim, MD, MPH; Charles P. Vega, MD

CME / ABIM MOC Released: 12/6/2022
Valid for credit through: 12/6/2023

Learn More

IDENTIFYING PATIENTS WITH PERIPHERAL ARTERY DISEASE: A CALL TO ACTION TO ASSESS AND SCREEN THE RIGHT PATIENTS

0.25 CME / ABIM MOC

Would you like to know more about assessing and screening the right patients for peripheral artery disease?

Authors: Soo Hyun (Esther) Kim, MD, MPH; Charles P. Vega, MD

CME / ABIM MOC Released: 11/30/2022
Valid for credit through: 11/30/2023

Learn More

TREATING PERIPHERAL ARTERY DISEASE IN THE MODERN WORLD: VASCULAR INSIGHTS INTO THE ROLE OF DUAL PATHWAY INHIBITION

0.75 CME

Are your patients with peripheral artery disease (PAD) on dual pathway inhibition? Listen as our experts discuss the latest data on this new treatment strategy.

Authors: Herbert D. Aronow, MD, MPH; Daniella Kadian-Dodov, MD; Esther S.H. Kim, MD, MPH, FSVM; Melissa Strickengloss, MSN, NP-C

CME/ ABIM MOC / CE Released: 11/17/2022
Valid for credit through: 11/17/2023

Learn More

WHAT VASCULAR SPECIALISTS NEED TO KNOW ABOUT ANTITHROMBOTIC STRATEGIES IN PERIPHERAL ARTERY DISEASE POST-REVASCULARIZATION

0.50 CME / ABIM MOC / CE

What is the most appropriate antithrombotic strategy after lower-extremity revascularization? Drs Aronow, Secemsky, and Washam discuss.

Authors: Herbert D. Aronow, MD, MPH, FACC, FSCAI, FSVM; Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM; Jeffrey B. Washam, PharmD, FAHA

Authors: Herbert D. Aronow, MD, MPH, FACC, FSCAI, FSVM; Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI, FSVM; Jeffrey B. Washam, PharmD, FAHA
CME / ABIM MOC / CE Released: 8/25/2022
Valid for credit through: 8/25/2023

Learn More

EVOLVING STRATEGIES IN PERIPHERAL ARTERY DISEASE POST-REVASCULARIZATION: INSIGHTS FOR THE VASCULAR TEAM

0.25 CME / ABIM MOC / CE

What is the most appropriate antithrombotic strategy post-revascularization? Drs Bonaca and Kadian-Dodov discuss.

Authors: Marc Bonaca, MD, MPH; Daniella Kadian-Dodov, MD

Authors: Marc Bonaca, MD, MPH; Daniella Kadian-Dodov, MD
CME / ABIM MOC / CE Released: 8/24/2022
Valid for credit through: 8/24/2023

Learn More

PERIPHERAL ARTERY DISEASE QUICKFIRE CASE CHALLENGES: WHERE DOES ANTITHROMBOTIC THERAPY FOR VASCULAR PROTECTION FIT?

0.25 CME / ABIM MOC / CE

How do you optimize antithrombotic therapy following revascularization? Drs Kolluri and Li discuss.

Authors: Raghu Kolluri, MD, MS, RVT, FSVM; Jun Li, MD, FACC, FSCAI

Authors: Raghu Kolluri, MD, MS, RVT, FSVM; Jun Li, MD, FACC, FSCAI
CME / ABIM MOC / CE Released: 8/25/2022
Valid for credit through: 8/25/2023

Learn More

CALLING ALL VASCULAR SPECIALISTS! INTERPROFESSIONAL APPROACHES TO IMPROVE PERIPHERAL ARTERY DISEASE MANAGEMENT TODAY

0.50 CME / ABIM MOC / CE

How can your vascular team improve the management of patients with peripheral artery disease (PAD)? An interprofessional team discusses.

Authors: Esther S.H. Kim, MD, MPH; Debra Kohlman-Trigoboff, ACNP-BC, CVN; Jennifer Anne Rymer, MD

Authors: Esther S.H. Kim, MD, MPH; Debra Kohlman-Trigoboff, ACNP-BC, CVN; Jennifer Anne Rymer, MD
CME / ABIM MOC / CE Released: 7/25/2022
Valid for credit through: 7/25/2023

Learn More

PERIPHERAL ARTERY DISEASE AND DUAL ANTITHROMBOTIC STRATEGIES: WHAT DO THE LATEST DATA SUGGEST?

0.25 CME / ABIM MOC / CE

What do you know about dual-pathway inhibition in patients with peripheral artery disease (PAD) undergoing lower-extremity revascularization? The experts discuss.

Authors: Geoffrey D. Barnes, MD, MSc; Marc Bonaca, MD, MPH

Authors: Geoffrey D. Barnes, MD, MSc; Marc Bonaca, MD, MPH
CME / ABIM MOC / CE Released: 7/7/2022
Valid for credit through: 7/7/2023

Learn More